Harrow Inc (HROW)
17.95
+0.11
(+0.62%)
USD |
NASDAQ |
May 31, 16:00
18.09
+0.14
(+0.78%)
After-Hours: 20:00
Harrow Gross Profit (Quarterly): 24.03M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 24.03M |
December 31, 2023 | 25.05M |
September 30, 2023 | 24.20M |
June 30, 2023 | 23.47M |
March 31, 2023 | 17.83M |
December 31, 2022 | 14.16M |
September 30, 2022 | 16.10M |
June 30, 2022 | 16.79M |
March 31, 2022 | 16.16M |
December 31, 2021 | 15.11M |
September 30, 2021 | 13.76M |
June 30, 2021 | 13.72M |
March 31, 2021 | 11.67M |
December 31, 2020 | 10.66M |
September 30, 2020 | 10.70M |
June 30, 2020 | 4.856M |
March 31, 2020 | 8.191M |
December 31, 2019 | 9.039M |
September 30, 2019 | 8.694M |
June 30, 2019 | 8.291M |
March 31, 2019 | 8.392M |
December 31, 2018 | 7.282M |
September 30, 2018 | 6.548M |
June 30, 2018 | 6.227M |
March 31, 2018 | 4.794M |
Date | Value |
---|---|
December 31, 2017 | 3.88M |
September 30, 2017 | 3.08M |
June 30, 2017 | 3.569M |
March 31, 2017 | 2.74M |
December 31, 2016 | 2.722M |
September 30, 2016 | 2.522M |
June 30, 2016 | 2.735M |
March 31, 2016 | 2.132M |
December 31, 2015 | 1.556M |
September 30, 2015 | 1.481M |
June 30, 2015 | 0.917M |
March 31, 2015 | 0.556M |
December 31, 2014 | 0.172M |
September 30, 2014 | 0.202M |
June 30, 2014 | 0.191M |
March 31, 2014 | 0.002M |
December 31, 2013 | 0.0025M |
September 30, 2013 | 0.0025M |
June 30, 2013 | 0.0025M |
March 31, 2013 | 0.0025M |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.10M |
December 31, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.856M
Minimum
Jun 2020
25.05M
Maximum
Dec 2023
14.62M
Average
13.96M
Median
Gross Profit (Quarterly) Benchmarks
Durect Corp | 1.538M |
Aquestive Therapeutics Inc | 7.664M |
Cyclacel Pharmaceuticals Inc | -- |
Stereotaxis Inc | 3.966M |
Cara Therapeutics Inc | 1.515M |